The Role of Epitranscriptomics in Development and Disease (R21 - Clinical Trial Not Allowed)

The summary for the The Role of Epitranscriptomics in Development and Disease (R21 - Clinical Trial Not Allowed) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
The Role of Epitranscriptomics in Development and Disease (R21 - Clinical Trial Not Allowed): The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications from the scientific community to support outstanding research in the area of epitranscriptomics, i.e., the chemical modifications of RNA. Evidence is accumulating that RNA modifications regulate the function of both coding and noncoding RNAs, suggesting that these modifications are involved in both development, and in health and disease. Yet the extent and types of these RNA modifications as well as their roles in particular biological processes remain either poorly understood or not known. The goal of the FOA is to promote research into the role of RNA chemical modifications in the initiation and progression of various developmental processes and disease states and conditions relevant to the scientific mission of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
Federal Grant Title: The Role of Epitranscriptomics in Development and Disease (R21 - Clinical Trial Not Allowed)
Federal Agency Name: National Institutes of Health (HHS-NIH11)
Grant Categories: Health Income Security and Social Services
Type of Opportunity: Discretionary
Funding Opportunity Number: PAR-18-831
Type of Funding: Grant
CFDA Numbers: 93.865
CFDA Descriptions: Information not provided
Current Application Deadline: June 3rd, 2021
Original Application Deadline: June 3rd, 2021
Posted Date: June 14th, 2018
Creation Date: June 14th, 2018
Archive Date: July 9th, 2021
Total Program Funding:
Maximum Federal Grant Award: $200,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Last Updated: June 14th, 2018
Applicants Eligible for this Grant
State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Link to Full Grant Announcement
http://grants.nih.gov/grants/guide/pa-files/PAR-18-831.html
Grant Announcement Contact
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants
Reproductive Medicine Collaborative Clinical Trials Program (Collaborative R01 Clinical Tr...
Novel Approaches to Safe, Non-Invasive, Real Time Assessment of Human Placenta Development...
Novel Approaches to Safe, Non-Invasive, Real Time Assessment of Human Placenta Development...
Pediatric Critical Care and Trauma Scientist Development Program (K12 Clinical Trial Optio...
Drug Transport Across the Blood-Testis and Blood-Epididymal Barriers (R61/R33 - Clinical T...
Phase II Small Business Technology Transfer Renewal Awards for Device Assessment or Precli...
Phase II Small Business Innovation Research Renewal Awards for Device Assessment or Precli...
Reproductive Genetics and Epigenetics
More Grants from the National Institutes of Health
Implementation Science for Cancer Control: Developing Centers (P50 Clinical Trial Optional...
Medications Development for the Treatment of Alcohol Use Disorder (U01 Clinical Trial Opti...
Enabling Technologies to Accelerate Development of Oral Biodevices (R01 Clinical Trial Not...
Enabling Technologies to Accelerate Development of Oral Biodevices (R21 Clinical Trial Not...
Implementation Science for Cancer Control: Advanced Centers (P50 Clinical Trial Optional)

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2018 FederalGrants.com